Evidence map›Paper›PMID 27624598›Full record

ArticlePsychopharmacology2016

Long-lasting effects of adolescent oxycodone exposure on reward-related behavior and gene expression in mice.

Victoria Sanchez, Marco D Carpenter, Nicole L Yohn, Julie A Blendy

Abstract read
In one paragraph

Article in Psychopharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. RGS9-2 Modulates Responses to Oxycodone in Pain-Free and Chronic Pain States.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Victoria SanchezDepartment of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Translational Research Laboratory, 125 South 31st Street, Philadelphia, PA19104, USA.
Marco D CarpenterDepartment of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Translational Research Laboratory, 125 South 31st Street, Philadelphia, PA19104, USA.
Nicole L YohnDepartment of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Translational Research Laboratory, 125 South 31st Street, Philadelphia, PA19104, USA.
Julie A BlendyDepartment of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Translational Research Laboratory, 125 South 31st Street, Philadelphia, PA19104, USA. blendy@mail.med.upenn.edu.
Translational Therapeutics (United States) · USUniversity of Pennsylvania · US

Funding

T32 Translational Addiction Research Fellowship ProgramT32DA028874 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI Julie A Blendy, Anna Rose Childress · 2010 to 2026
$5.0M
Transgenerational Effects of Drug-exposure: Epigenetic and Behavioral ImpactR01DA033646 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI BARTOLOMEI, MARISA S., BLENDY, JULIE A · 2012 to 2016
$2.1M
Behavioral and epigenetic changes following adolescent oxycodone exposureR21DA044017 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI BLENDY, JULIE A · 2017 to 2018
$443k
NEUROBIOLOGY OF COCAINE-INDUCED BEHVRL SENSITIZATIONF32DA005589 · NIDA · WASHINGTON STATE UNIVERSITY · PI PIERCE, ROBERT CHRISTOPHER · 1993 to 1995
–
NIDA NIH HHS F32 DA005589NIDA NIH HHS R01 DA033646NIDA NIH HHS R21 DA044017NIDA NIH HHS T32 DA028874
6 · The paper itself

Abstract

rationalePrescription opioid abuse and transition to heroin use are growing problems in the USA. However, the long-term consequences of adolescent prescription opioid abuse on subsequent drug use and affective-like behavior are unknown.

objectivesThis study aims to determine if adolescent exposure to oxycodone alters the rewarding effects of morphine, anxiety-like behavior, and reward-related gene expression later in adulthood.

methodsAdolescent male C57Bl/6 mice were exposed to oxycodone (3 mg/kg/day) via osmotic minipumps for 28 days. Following a 28-day withdrawal period, mice were tested in morphine-conditioned place preference paradigm (CPP), morphine sensitization, open field, marble burying, and forced swim (FST) tests. To determine if effects were specific to adolescent exposure, adult mice were exposed to oxycodone for 28 days and underwent 28 days of withdrawal prior to the same behavioral testing schedule. Expression of reward-related genes including dopamine receptor 1 (D1) and dopamine transporter (DAT) in the nucleus accumbens (NAc) and ventral tegmental area (VTA) was examined.

resultsAdolescent oxycodone exposure significantly increased (300 %) response to morphine CPP during adulthood and significantly reduced D1 expression (30 %) in the NAc and DAT expression (75 %) in the VTA. Adult oxycodone exposure did not affect subsequent responses to morphine CPP. Oxycodone exposure did not affect the development of morphine sensitization or affective-like behaviors. Corticosterone response to a stressor (FST) was significantly reduced (65 %) in mice exposed to oxycodone during adolescence but not adulthood.

conclusionsAdolescent oxycodone exposure enhances rewarding effects of morphine in adulthood with no effect on other affective-like behaviors.

Indexed as

RewardAnalysis of VarianceAnimalsAnxietyBehavior, AnimalDopamine Plasma Membrane Transport ProteinsGene Expression RegulationMaleMiceMice, Inbred C57BLMorphineNarcoticsNucleus AccumbensOxycodoneReceptors, DopamineVentral Tegmental AreaDopamine Plasma Membrane Transport ProteinsMorphineNarcoticsOxycodoneReceptors, DopamineAnxietyConditioned place preferenceDopamineMorphineOpioidOxycodoneReward

Identifiers

PMID27624598
PMCPMC5992616
OpenAlexW2520873324

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.